Cooper Investors PTY Ltd. Grows Stock Position in Kenvue Inc. (NYSE:KVUE)

Cooper Investors PTY Ltd. lifted its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 39.7% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 858,076 shares of the company's stock after purchasing an additional 244,043 shares during the quarter. Kenvue accounts for about 3.3% of Cooper Investors PTY Ltd.'s holdings, making the stock its 9th largest position. Cooper Investors PTY Ltd.'s holdings in Kenvue were worth $20,577,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Asset Management One Co. Ltd. grew its position in Kenvue by 6.9% during the first quarter. Asset Management One Co. Ltd. now owns 801,376 shares of the company's stock worth $19,217,000 after buying an additional 51,796 shares in the last quarter. Oppenheimer & Co. Inc. grew its position in Kenvue by 5.3% during the first quarter. Oppenheimer & Co. Inc. now owns 172,255 shares of the company's stock worth $4,131,000 after buying an additional 8,693 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in shares of Kenvue by 0.6% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 1,341,054 shares of the company's stock worth $32,158,000 after purchasing an additional 7,739 shares in the last quarter. Continuum Advisory LLC boosted its holdings in shares of Kenvue by 2,071.1% in the 1st quarter. Continuum Advisory LLC now owns 1,954 shares of the company's stock worth $47,000 after purchasing an additional 1,864 shares in the last quarter. Finally, TrueMark Investments LLC boosted its holdings in shares of Kenvue by 10.7% in the 1st quarter. TrueMark Investments LLC now owns 211,025 shares of the company's stock worth $5,060,000 after purchasing an additional 20,430 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on KVUE. Canaccord Genuity Group upped their price objective on Kenvue from $24.00 to $29.00 and gave the stock a "buy" rating in a report on Wednesday, March 5th. Evercore ISI began coverage on Kenvue in a research note on Monday, March 24th. They issued an "in-line" rating and a $25.00 target price for the company. UBS Group boosted their target price on Kenvue from $24.00 to $25.00 and gave the company a "neutral" rating in a research note on Friday, May 9th. Redburn Atlantic began coverage on Kenvue in a research note on Thursday, April 10th. They issued a "neutral" rating and a $23.50 target price for the company. Finally, Piper Sandler boosted their target price on Kenvue from $24.00 to $27.00 and gave the company an "overweight" rating in a research note on Monday, February 24th. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $25.33.

Kenvue Price Performance

NYSE:KVUE opened at $21.39 on Tuesday. The firm has a market capitalization of $41.04 billion, a price-to-earnings ratio of 38.89, a PEG ratio of 3.32 and a beta of 0.98. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $25.17. The business has a 50 day simple moving average of $22.99 and a 200-day simple moving average of $22.40. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.86 and a quick ratio of 0.60.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.24 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.01. The firm had revenue of $3.74 billion for the quarter, compared to the consensus estimate of $3.69 billion. Kenvue had a return on equity of 20.87% and a net margin of 6.90%. The company's revenue for the quarter was down 3.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.28 earnings per share. Equities analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th were given a $0.205 dividend. This represents a $0.82 annualized dividend and a dividend yield of 3.83%. The ex-dividend date of this dividend was Wednesday, May 14th. Kenvue's payout ratio is 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.